Time filter

Source Type

Bournemouth, United Kingdom

Everett J.,Bournemouth Diabetes and Endocrine Center | Kerr D.,Bournemouth University
Practical Diabetes International | Year: 2010

New National Institute for Health and Clinical Excellence guidance is likely to increase the use of insulin pump therapy, and the challenge for diabetes teams is to maintain the initial improvement in HbA1c without extra resources. A telehealth system has been developed where both health professionals and patients can view downloaded pump and blood glucose data. A pilot study in patients with HbA1c >8%, using pump therapy for more than a year, demonstrated a mean reduction from 9.3% to 8.2% at 12 months after using the telehealth system. Patient satisfaction with the system reported more understanding, insight and control by viewing the data, as well as easy access to the health professional. This pilot study has demonstrated that, for some people, using a telehealth approach has resulted in improved diabetes control. Copyright © 2010 John Wiley & Sons. Source

Shaban C.,Bournemouth Diabetes and Endocrine Center
European Diabetes Nursing | Year: 2010

For many people with diabetes there are visible consequences that may contribute to the development of a negative body image. However, there is a dearth of literature concerning the effect of diabetes on body image and physical intimacy. The extent of body image-related distress can lead to suboptimal glycaemic control and perpetuate the problem. This article presents a psychological model to understand the contribution of diabetes mismanagement as a coping strategy in the reduction of emotional distress. To reduce body image-related distress, it is essential that treatments integrate both psychological and diabetes-related factors. Negative body image can be treated successfully with cognitive behavioural therapy but further research is required into the triad of body image, intimacy and diabetes. Copyright © 2010 FEND Copyright © 2010 FEND. Source

Holt H.,Bournemouth Diabetes and Endocrine Center
Practical Diabetes | Year: 2015

This NICE guidance for the management of diabetes in pregnancy is timely and considered. Some areas are controversial, particularly the diagnostic criteria for GDM. However, in this area and most others the GDG have made a good job of reviewing the extensive literature to produce a guideline which is cost effective but is also pragmatic and emphasises the importance of treating women as individuals. © 2015 JOHN WILEY & SONS. Source

Kerr D.,Bournemouth Diabetes and Endocrine Center | Messing R.,Abbott Laboratories | Resch A.,Abbott Laboratories
Journal of Diabetes Science and Technology | Year: 2011

Self-monitoring of blood glucose (SMBG) values is an accepted requirement for patients with diabetes using multiple daily injections of insulin. Nevertheless, for many patients, the full value of SMBG has yet to be realized due to a number of factors that contribute to patients not taking appropriate action based on the achieved result. The reasons for this are complex but are related to the burden imposed by performing the tests, the need for complex numerical calculations, and the demand for undertaking this activity multiple times each day. In the near future, SMBG devices are likely to include technological innovations that are aimed at overcoming these barriers, offering "actionable" SMBG for patients using insulin. These innovations should include technologies that will allow customization and individualization based upon specific therapy regimens. © Diabetes Technology Society. Source

Choudhary P.,Kings College London | Shin J.,Northridge | Wang Y.,Northridge | Evans M.L.,University of Cambridge | And 5 more authors.
Diabetes Care | Year: 2011

OBJECTIVE - To evaluate a sensor-augmented insulin pump with a low glucose suspend (LGS) feature that automatically suspends basal insulin delivery for up to 2 h in response to sensor-detected hypoglycemia. RESEARCH DESIGN AND METHODS - The LGS feature of the Paradigm Veo insulin pump (Medtronic, Inc., Northridge, CA) was tested for 3 weeks in 31 adults with type 1 diabetes. RESULTS - There were 166 episodes of LGS: 66% of daytime LGS episodes were terminated within 10 min, and 20 episodes lasted the maximum 2 h. LGS use was associated with reduced nocturnal duration ≤2.2 mmol/L in those in the highest quartile of nocturnal hypoglycemia at baseline (median 46.2 vs. 1.8min/day, P = 0.02 [LGS-OFF vs. LGS-ON]).Median sensor glucose was 3.9 mmol/L after 2-h LGS and 8.2 mmol/L at 2 h after basal restart. CONCLUSIONS - Use of an insulin pump with LGS was associated with reduced nocturnal hypoglycemia in those at greatest risk and was well accepted by patients. © 2011 by the American Diabetes Association. Source

Discover hidden collaborations